Strybol Kaat Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Strybol Kaat Pharma
Largest movements
- Receivables after one year -€25,000
down €25,000 (-100%), from €25,000 to €0
- Receivables within one year +€13,506
up €13,506 (+60.2%), from €22,427 to €35,933
of which Other amounts receivable: +€13,506
- Debts after one year -€37,500
down €37,500 (-5.7%), from €653,125 to €615,625
- Reserves +€35,060
up €35,060 (+87.0%), from €40,312 to €75,372
- Depreciation -€5,518
down €5,518 (-73.1%), from €7,544 to €2,026
- Taxes +€2,385
up €2,385 (+22.8%), from €10,462 to €12,847
- Gross operating margin -€2,065
down €2,065 (-2.8%), from €74,511 to €72,446
- Financial charges -€1,713
down €1,713 (-6.8%), from €25,063 to €23,350
- Financial income -€980
down €980 (-36.4%), from €2,690 to €1,710
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €759,405 | €749,285 | -€10,120 | -1.3% |
| Fixed assets | 21/28 | €705,833 | €706,340 | +€507 | +0.1% |
| Tangible fixed assets | 22/27 | €6,083 | €6,590 | +€507 | +8.3% |
| Furniture and vehicles | 24 | €2,786 | €6,590 | +€3,804 | +137% |
| Leasing and similar rights | 25 | €3,297 | €0 | -€3,297 | -100% |
| Financial fixed assets | 28 | €699,750 | €699,750 | = | 0.0% |
| Current assets | 29/58 | €53,572 | €42,945 | -€10,626 | -19.8% |
| Amounts receivable after more than one year | 29 | €25,000 | €0 | -€25,000 | -100% |
| Other amounts receivable | 291 | €25,000 | €0 | -€25,000 | -100% |
| Amounts receivable within one year | 40/41 | €22,427 | €35,933 | +€13,506 | +60.2% |
| Trade receivables | 40 | €0 | - | = | |
| Other amounts receivable | 41 | €22,427 | €35,933 | +€13,506 | +60.2% |
| Cash at bank and in hand | 54/58 | €5,347 | €6,125 | +€778 | +14.5% |
| Deferred charges and accrued income | 490/1 | €798 | €888 | +€90 | +11.2% |
| Total equity and liabilities | 10/49 | €759,405 | €749,285 | -€10,120 | -1.3% |
| Equity | 10/15 | €46,512 | €81,572 | +€35,060 | +75.4% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €40,312 | €75,372 | +€35,060 | +87.0% |
| Distributable reserves | 133 | €40,312 | €75,372 | +€35,060 | +87.0% |
| Amounts payable | 17/49 | €712,893 | €667,713 | -€45,180 | -6.3% |
| Amounts payable after more than one year | 17 | €653,125 | €615,625 | -€37,500 | -5.7% |
| Financial debts | 170/4 | €653,125 | €615,625 | -€37,500 | -5.7% |
| Amounts payable within one year | 42/48 | €53,471 | €45,374 | -€8,097 | -15.1% |
| Current portion of amounts payable after more than one year | 42 | €44,826 | €37,500 | -€7,326 | -16.3% |
| Trade debts | 44 | €2,025 | €922 | -€1,103 | -54.5% |
| Suppliers | 440/4 | €2,025 | €922 | -€1,103 | -54.5% |
| Taxes, remuneration and social security | 45 | €5,681 | €6,486 | +€805 | +14.2% |
| Taxes | 450/3 | €5,681 | €6,486 | +€805 | +14.2% |
| Other amounts payable | 47/48 | €939 | €466 | -€472 | -50.3% |
| Accrued charges and deferred income | 492/3 | €6,297 | €6,714 | +€417 | +6.6% |
| Non-recurring operating income | 76A | - | €1,978 | +€1,978 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,544 | €2,026 | -€5,518 | -73.1% |
| Other operating charges | 640/8 | €1,111 | €873 | -€237 | -21.4% |
| Non-recurring operating charges | 66A | €9 | €0 | -€9 | -100% |
| Gross operating margin | 9900 | €74,511 | €72,446 | -€2,065 | -2.8% |
| Operating profit (loss) | 9901 | €65,847 | €69,547 | +€3,700 | +5.6% |
| Financial income | 75/76B | €2,690 | €1,710 | -€980 | -36.4% |
| Recurring financial income | 75 | €2,690 | €1,710 | -€980 | -36.4% |
| Financial charges | 65/66B | €25,063 | €23,350 | -€1,713 | -6.8% |
| Recurring financial charges | 65 | €25,063 | €23,350 | -€1,713 | -6.8% |
| Profit (loss) for the period before taxes | 9903 | €43,474 | €47,907 | +€4,433 | +10.2% |
| Income taxes | 67/77 | €10,462 | €12,847 | +€2,385 | +22.8% |
| Profit (loss) for the period | 9904 | €33,012 | €35,060 | +€2,049 | +6.2% |
| Profit (loss) for the period to be appropriated | 9905 | €33,012 | €35,060 | +€2,049 | +6.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.